HBE Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$337K Buy
291
+1
+0.3% +$1.18K 0.24% 40
2026
Q2
$348K Sell
290
-2
-0.7% -$2.04K 0.25% 40
2026
Q1
$269K Buy
292
+59
+25% +$59.8K 0.23% 43
2025
Q4
$250K Buy
+233
New +$223K 0.24% 40

Other funds holding LLY

HBE Wealth Management's LLY Position: Q3 2026 in Review

HBE Wealth Management increased its Eli Lilly (LLY) stake by 0.34% in Q3 2026, buying an estimated $1.18K and bringing the position to 291 shares worth $337K. The position accounts for 0.24% of the portfolio, ranked #40.

HBE Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $348K in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • HBE Wealth Management held 291 shares of Eli Lilly worth $337K as of Q3 2026.
  • HBE Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
  • Eli Lilly made up 0.24% of HBE Wealth Management's portfolio in Q3 2026, its #40 holding.
  • HBE Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • HBE Wealth Management's Eli Lilly position peaked at $348K in Q2 2026.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on HBE Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.